Back to search
FDAFDA · Food and drugs·Recall number D-0648-2017

Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA, Inc., South Francisco, CA. 94080, NDC 50242-717-01,UPC 3 50242-717-01.

Published April 12, 2017 · Recall initiated: March 13, 2017

Summary

FDA records drug Class II recall D-0648-2017, published April 12, 2017 and initiated March 13, 2017. Recalling firm: Genentech Inc.; Status: Terminated; Reported quantity: 748 bottles; Lot: B1009MC, B1009M9, B1009MA; Exp. 02/18 B1009MT 02/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: An oversized tablet was found in a bottle.

What to do

Voluntary: Firm initiated · Letter

Get an email if COTELLIC has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
COTELLIC
Manufacturer
Genentech Inc.
Distributor
NJ and IL
Lot
B1009MC, B1009M9, B1009MA; Exp. 02/18 B1009MT 02/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA, Inc., South Francisco, CA. 94080, NDC 50242-717-01,UPC 3 50242-717-01. recalled?

Yes. FDA published recall D-0648-2017 on April 12, 2017. Reported hazard: Superpotent Drug: An oversized tablet was found in a bottle.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: COTELLIC.